GSK plc

LSE-GSK

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						33,754	24,354	24,696	29,324	30,328	31,446
Total Revenues % Chg.						9.5%	-27.8%	1.4%	18.7%	3.4%	7.2%
Cost of Goods Sold, Total						10,792	7,321	8,033	9,407	8,388	8,561
Gross Profit						22,962	17,033	16,663	19,917	21,940	22,885
Selling General & Admin Expenses, Total						10,962	7,041	6,784	8,179	9,156	9,284
R&D Expenses						4,405	4,397	4,627	5,153	5,823	6,049
Other Operating Expenses						-606	-455	-382	-737	-1,442	-1,434
Other Operating Expenses, Total						14,761	10,983	11,029	12,595	13,537	13,899
Operating Income						8,201	6,050	5,634	7,322	8,403	8,986
Interest Expense, Total						-877	-844	-762	-819	-710	-663
Interest And Investment Income						79	26	13	62	108	102
Net Interest Expenses						-798	-818	-749	-757	-602	-561
Income (Loss) On Equity Invest.						74	33	33	-2	-5	-3
Other Non Operating Income (Expenses)						-12	-24	-6	-46	-75	-75
EBT, Excl. Unusual Items						7,465	5,241	4,912	6,517	7,721	8,347
Restructuring Charges	—	—				-1,110	-1,178	-424	-321	-382	-408
Gain (Loss) On Sale Of Investments						-14	-242	1	256	-121	-122
Gain (Loss) On Sale Of Assets						541	2,857	552	215	61	61
Asset Writedown	—	—	—			-83	-200	-347	-296	-398	-479
Legal Settlements	—	—	—	—	—	—	—	—	922	—	—
Other Unusual Items						-578	-1,308	-1,095	-1,665	-817	-2,379
EBT, Incl. Unusual Items						6,221	5,170	3,599	5,628	6,064	5,020
Income Tax Expense						953	67	83	707	756	703
Earnings From Continuing Operations						5,268	5,103	3,516	4,921	5,308	4,317
Earnings Of Discontinued Operations	—	—	—	—	—	—	876	1,069	10,495	—	—
Minority Interest						-623	-230	-200	-460	-380	-284
Net Income						4,645	5,749	4,385	14,956	4,928	4,033
Net Income to Common Incl Extra Items						4,645	5,749	4,385	14,956	4,928	4,033
Net Income to Common Excl. Extra Items						4,645	4,873	3,316	4,461	4,928	4,033
Total Shares Outstanding						3,962.6	3,984.8	4,006.9	4,034.3	4,056.3	4,079
Weighted Avg. Shares Outstanding						3,957.6	3,981	4,003	4,026	4,052	4,065
Weighted Avg. Shares Outstanding Dil						4,012.8	4,030	4,052	4,084	4,111	4,125
EPS						1.2	1.4	1.1	3.7	1.2	1
EPS Diluted						1.2	1.4	1.1	3.7	1.2	1
EBITDA						10,321	8,100	7,756	9,089	10,304	10,983
Effective Tax Rate						15.3%	1.3%	2.3%	12.6%	12.5%	14%